Solazyme Inc. (NASDAQ:TVIA) was up 3% during mid-day trading on Monday . The stock traded as high as $2.45 and last traded at $2.44, with a volume of 163,514 shares changing hands. The stock had previously closed at $2.37.

The stock’s market capitalization is $208.09 million. The stock’s 50 day moving average is $2.40 and its 200 day moving average is $2.06.

Solazyme (NASDAQ:TVIA) last posted its quarterly earnings results on Wednesday, May 4th. The company reported ($0.27) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.02. During the same period last year, the firm posted ($0.37) earnings per share. The company earned $10.90 million during the quarter, compared to the consensus estimate of $11.94 million. The company’s revenue for the quarter was down 13.5% on a year-over-year basis. Analysts predict that Solazyme Inc. will post ($1.12) earnings per share for the current fiscal year.

In other Solazyme news, CFO Tyler Painter sold 12,500 shares of Solazyme stock in a transaction on Tuesday, June 7th. The shares were sold at an average price of $2.67, for a total value of $33,375.00. Following the completion of the sale, the chief financial officer now directly owns 400,337 shares of the company’s stock, valued at $1,068,899.79. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Solazyme, Inc creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora SA and its affiliates, QVC, Inc, SpaceNK Limited, select Nordstrom stores and ULTA Beauty.